Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy

Area of Science:

• Immunology
• Metabolism
• Oncology

Background:

• Immune metabolism is a rapidly advancing field offering novel therapeutic targets for cancer.
• Combination therapies integrating metabolic inhibitors with traditional treatments like immunotherapy show promise.
• The tumor microenvironment (TME) presents complex challenges and opportunities for metabolic interventions in cancer therapy.

Purpose of the Study:

• To explore current strategies for modulating immune cell metabolism within the TME.
• To highlight the need for improved methods to study metabolic targets in physiologic conditions.
• To underscore the importance of understanding metabolic pathways for enhancing cancer immunotherapy.

Main Methods:

• Review of current literature on immune metabolism and cancer therapy.
• Analysis of oncogene-driven metabolic changes in tumor cells and their impact on the TME.
• Exploration of strategies to shift immune cell metabolism towards anti-tumor states.

Main Results:

• Oncogene-induced metabolic reprogramming in tumors can suppress anti-cancer immunity within the TME.
• Targeting metabolic pathways offers opportunities to reshape the TME and enhance immune responses.
• Current strategies aim to shift immune cell metabolism to pro-inflammatory phenotypes.

Conclusions:

• Understanding the interplay between tumor metabolism and the TME is essential for effective cancer therapy.
• Further research is needed to optimize metabolic inhibitors and their application in combination treatments.
• Advancing the field of immune metabolism will be key to improving immunotherapy efficacy.